October 30, 2015: Preventing Medication Errors with New High-Concentration Insulins
Until very recently, all insulin products for human use in Canada were available in only one concentration: 100 units/mL. In 2015, Health Canada authorized 2 new high-concentration insulin products: Toujeo SoloSTAR (insulin glargine) 300 units/mL prefilled pen and Humalog (insulin lispro) 200 units/mL KwikPen prefilled pen. The new products are available only in pen format. Despite this design enhancement, the introduction of any new product into an established line of similar medications introduces the potential for new medication errors to occur. Read more...
